Lisa Decker

Lisa Decker is the Chief Business Officer at IGM Biosciences, where they are engaged in pioneering the development of engineered IgM antibodies. They hold a PhD in Immunology from Tufts University, where they also studied as a graduate student from 1992 to 1998. Previously, Decker served as the Associate Director at the University of Massachusetts Medical School, managing licensing and intellectual property for early stage biomedical technologies from 2000 to 2008, and held executive roles at Nektar Therapeutics and Atreca, Inc. They currently serve on the Board of Directors at Chimerix, Inc.